CircHIPK3 Facilitates the G2/M Transition in Prostate Cancer Cells by Sponging miR-338-3p.
Cdc25B
G2/M transition
circHIPK3
miR-338-3p
prostate cancer
Journal
OncoTargets and therapy
ISSN: 1178-6930
Titre abrégé: Onco Targets Ther
Pays: New Zealand
ID NLM: 101514322
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
12
2019
accepted:
01
05
2020
entrez:
18
6
2020
pubmed:
18
6
2020
medline:
18
6
2020
Statut:
epublish
Résumé
Circular RNAs (circRNAs) play a crucial role in gene expression regulation. CircHIPK3 is a circRNA derived from Exon 2 of HIPK3 gene and its role in prostate cancer (PCa) is still unclear. CCK8 assays, flow cytometry and colony formation assays were performed to assess the effects of circHIPK3 in PCa cells. Bioinformatics analysis, RNA pull-down assay, RNA immunoprecipitation assay (RIP), and luciferase activity assay were performed to dissect the mechanism underlying circHIPK3-mediated G2/M transition in PCa cells. CircHIPK3 expression was upregulated in PCa cells and prostate cancer tissues. Overexpression of circHIPK3 or circHIPK3 silencing altered PCa viability, proliferation and apoptosis in vitro. CircHIPK3 could sponge miR-338-3p and inhibit its activity, resulting in increased expression of Cdc25B and Cdc2 in vitro. CircHIPK3 promotes G2/M transition and induces PCa cell proliferation by sponging miR-338-3p and increasing the expression of Cdc25B and Cdc2. CircHIPK3 may play an oncogenic role in PCa.
Sections du résumé
BACKGROUND
BACKGROUND
Circular RNAs (circRNAs) play a crucial role in gene expression regulation. CircHIPK3 is a circRNA derived from Exon 2 of HIPK3 gene and its role in prostate cancer (PCa) is still unclear.
METHODS
METHODS
CCK8 assays, flow cytometry and colony formation assays were performed to assess the effects of circHIPK3 in PCa cells. Bioinformatics analysis, RNA pull-down assay, RNA immunoprecipitation assay (RIP), and luciferase activity assay were performed to dissect the mechanism underlying circHIPK3-mediated G2/M transition in PCa cells.
RESULTS
RESULTS
CircHIPK3 expression was upregulated in PCa cells and prostate cancer tissues. Overexpression of circHIPK3 or circHIPK3 silencing altered PCa viability, proliferation and apoptosis in vitro. CircHIPK3 could sponge miR-338-3p and inhibit its activity, resulting in increased expression of Cdc25B and Cdc2 in vitro.
CONCLUSION
CONCLUSIONS
CircHIPK3 promotes G2/M transition and induces PCa cell proliferation by sponging miR-338-3p and increasing the expression of Cdc25B and Cdc2. CircHIPK3 may play an oncogenic role in PCa.
Identifiants
pubmed: 32547085
doi: 10.2147/OTT.S242482
pii: 242482
pmc: PMC7251229
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4545-4558Informations de copyright
© 2020 Liu et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interest.
Références
Oncogene. 2003 Feb 6;22(5):734-9
pubmed: 12569365
Nat Rev Mol Cell Biol. 2016 Apr;17(4):205-11
pubmed: 26908011
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Am J Cancer Res. 2018 Dec 01;8(12):2564-2574
pubmed: 30662812
Mol Cell Biochem. 2016 May;416(1-2):33-46
pubmed: 27038604
Nucleic Acids Res. 2015 Mar 11;43(5):2525-34
pubmed: 25690898
Oncogene. 2018 Feb 1;37(5):555-565
pubmed: 28991235
Gene. 2018 Jan 5;638:13-19
pubmed: 28964895
EMBO Rep. 2017 Sep;18(9):1646-1659
pubmed: 28794202
Cancer Manag Res. 2019 Feb 12;11:1415-1423
pubmed: 30863152
Circulation. 2017 Oct 24;136(17):1629-1642
pubmed: 28860123
J Clin Oncol. 2017 Sep 20;35(27):3097-3104
pubmed: 28796587
Cell Death Dis. 2018 May 9;9(5):522
pubmed: 29743567
Oncogene. 2017 Nov 2;36(44):6177-6189
pubmed: 28869606
RNA Biol. 2016;13(1):34-42
pubmed: 26669964
Cell Death Dis. 2018 Mar 16;9(4):417
pubmed: 29549306
Hepatology. 2015 Oct;62(4):1145-59
pubmed: 26082033
PLoS One. 2012;7(2):e30733
pubmed: 22319583
Bioinformatics. 2014 Aug 15;30(16):2243-6
pubmed: 24764460
Nat Commun. 2016 Apr 06;7:11215
pubmed: 27050392
Am J Cancer Res. 2017 Jan 01;7(1):53-63
pubmed: 28123847
Cell. 2019 Feb 7;176(4):869-881.e13
pubmed: 30735636
Nature. 2013 Mar 21;495(7441):333-8
pubmed: 23446348
Elife. 2015 Jun 09;4:e07540
pubmed: 26057830
Hepatology. 2017 Oct;66(4):1151-1164
pubmed: 28520103
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Am J Pathol. 2006 Nov;169(5):1812-20
pubmed: 17071602
RNA. 2013 Feb;19(2):141-57
pubmed: 23249747
Am J Transl Res. 2016 Jul 15;8(7):3266-73
pubmed: 27508048
Eur Urol. 2018 Oct;74(4):413-419
pubmed: 29306514
Onco Targets Ther. 2019 May 02;12:3363-3372
pubmed: 31118688
Cell Death Dis. 2017 Jul 13;8(7):e2928
pubmed: 28703807
J Natl Compr Canc Netw. 2016 Jan;14(1):19-30
pubmed: 26733552
J Cell Sci. 2004 Oct 1;117(Pt 21):4979-90
pubmed: 15456846